Trial
NCT03209401
Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
Tesaro, Inc.; Oregon Health and Science University
Condition
Solid Tumor, Adult
Intervention
Niraparib
Why stopped
Lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-05